@return2ozma to News • 1 year agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square158arrow-up1618arrow-down117cross-posted to: [email protected][email protected][email protected][email protected]health
arrow-up1601arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.com@return2ozma to News • 1 year agomessage-square158cross-posted to: [email protected][email protected][email protected][email protected]health
minus-square@EnderMBlink7•11 months agoI’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap. The problem still stands, though, and the solution is capping executive pay in public companies.
I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.
The problem still stands, though, and the solution is capping executive pay in public companies.